StockDriftsStockDriftsTop 38 Defilade Capital Management L P Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 6.28% | 39.1K | $46.9M | +88.86%(+18.39K) | $977.27(+23.71%) | 2026-06-30 | |
| PFE | PFIZER INC | 5.71% | 1.77M | $42.7M | +21.01%(+307.61K) | $25.32(+5.86%) | 2026-06-30 | |
| VEEV | VEEVA SYS INC | 5.62% | 236.7K | $42.0M | new | $176.72(+42.96%) | 2026-06-30 | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 5.22% | 682.0K | $39.0M | new | $56.01(+22.36%) | 2026-06-30 | |
| PTCT | PTC THERAPEUTICS INC | 4.74% | 433.7K | $35.4M | +15.29%(+57.53K) | $72.25(-0.39%) | 2026-06-30 | |
| BAX | BAXTER INTL INC | 4.17% | 1.46M | $31.1M | new | $18.56(+45.74%) | 2026-06-30 | |
| INSM | INSMED INC | 4.02% | 281.8K | $30.0M | +44.60%(+86.93K) | $155.08(-18.54%) | 2026-06-30 | |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 3.66% | 317.4K | $27.3M | -45.19%(-261.74K) | $90.17(+10.42%) | 2026-06-30 | |
| PODD | INSULET CORP | 3.61% | 176.9K | $26.9M | new | $180.13(-18.70%) | 2026-06-30 | |
| TMO | THERMO FISHER SCIENTIFIC INC | 3.49% | 51.9K | $26.0M | new | $490.70(+21.44%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (2 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — | +5.92% |
| Top 20 Holdings Unweighted | — | — | — | — | +8.67% |
Defilade Capital Management L P reports $746.95M in US-listed equity holdings across 39 positions in its most recent 13F filing. Its largest disclosed positions are LLY (6.3%), PFE (5.7%) and VEEV (5.6%). The top 20 holdings account for 72.73% of reported assets. Its disclosed equity book has returned +5.92% cumulatively over 2 quarters. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Defilade Capital Management L P, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Defilade Capital Management L P’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 2088557). View Defilade Capital Management L P’s 13F filings on SEC